XML 29 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Apr. 30, 2019 $ 47,100 $ 6,875 $ 3,133 $ (53) $ 43,552 $ (6,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 471       471  
Other comprehensive income (loss) 195         195
Cash dividends paid (522)       (522)  
Stock based compensation 60 9 51      
Ending balance at Jul. 31, 2019 47,304 6,884 3,184 (53) 43,501 (6,212)
Beginning balance at Apr. 30, 2019 47,100 6,875 3,133 (53) 43,552 (6,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (3,625)          
Other comprehensive income (loss) (8)          
Ending balance at Jan. 31, 2020 42,649 6,885 3,350 (53) 38,882 (6,415)
Beginning balance at Jul. 31, 2019 47,304 6,884 3,184 (53) 43,501 (6,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (2,178)       (2,178)  
Other comprehensive income (loss) (177)         (177)
Cash dividends paid (523)       (523)  
Stock based compensation 42   42      
Ending balance at Oct. 31, 2019 44,468 6,884 3,226 (53) 40,800 (6,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (1,918)       (1,918)  
Other comprehensive income (loss) (26)         (26)
Stock options exercised 0 1 (1)      
Stock based compensation 125   125      
Ending balance at Jan. 31, 2020 42,649 6,885 3,350 (53) 38,882 (6,415)
Beginning balance at Apr. 30, 2020 38,415 6,885 3,360 (53) 37,821 (9,598)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (598)       (598)  
Other comprehensive income (loss) (13)         (13)
Stock based compensation 98 20 78      
Ending balance at Jul. 31, 2020 37,902 6,905 3,438 (53) 37,223 (9,611)
Beginning balance at Apr. 30, 2020 38,415 6,885 3,360 (53) 37,821 (9,598)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (697)          
Other comprehensive income (loss) (17)          
Ending balance at Jan. 31, 2021 38,055 6,915 3,684 (53) 37,124 (9,615)
Beginning balance at Jul. 31, 2020 37,902 6,905 3,438 (53) 37,223 (9,611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (180)       (180)  
Other comprehensive income (loss) (35)         (35)
Stock based compensation 143   143      
Ending balance at Oct. 31, 2020 37,830 6,905 3,581 (53) 37,043 (9,646)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 81       81  
Other comprehensive income (loss) 31         31
Stock based compensation 113 10 103      
Ending balance at Jan. 31, 2021 $ 38,055 $ 6,915 $ 3,684 $ (53) $ 37,124 $ (9,615)